Two Alzheimer’s Organizations to Fund Phase 2 Trial of Amylyx Combo Therapy
News
The Alzheimer’s Association and Alzheimer’s Drug Discovery Foundation will fund a Phase 2 clinical trial of a combination therapy that Amylyx Pharmaceuticals is developing for Alzheimer’s disease. Amylyx will receive $1.85 million ... Read more